GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OSTO:VIMIAN) » Definitions » Debt-to-Equity

Vimian Group AB (OSTO:VIMIAN) Debt-to-Equity : 0.32 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB Debt-to-Equity?

Vimian Group AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr51 Mil. Vimian Group AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr2,400 Mil. Vimian Group AB's Total Stockholders Equity for the quarter that ended in Mar. 2025 was kr7,556 Mil. Vimian Group AB's debt to equity for the quarter that ended in Mar. 2025 was 0.32.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vimian Group AB's Debt-to-Equity or its related term are showing as below:

OSTO:VIMIAN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.27   Med: 0.42   Max: 0.85
Current: 0.32

During the past 8 years, the highest Debt-to-Equity Ratio of Vimian Group AB was 0.85. The lowest was 0.27. And the median was 0.42.

OSTO:VIMIAN's Debt-to-Equity is ranked worse than
54.5% of 189 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs OSTO:VIMIAN: 0.32

Vimian Group AB Debt-to-Equity Historical Data

The historical data trend for Vimian Group AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Debt-to-Equity Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial 0.38 0.51 0.46 0.60 0.33

Vimian Group AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.27 0.38 0.33 0.32

Competitive Comparison of Vimian Group AB's Debt-to-Equity

For the Diagnostics & Research subindustry, Vimian Group AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Debt-to-Equity falls into.


;
;

Vimian Group AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vimian Group AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Vimian Group AB's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB  (OSTO:VIMIAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Vimian Group AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines